StockNews.AISignal intelligence
Donaldson Company, Inc. · NYSE · Industrials
Browse public DCI signals with their source context and measured market impact. Open any signal for its permanent analysis page.
DCI's Q1 fiscal 2026 sales rose 3.9% year-over-year to $935.4 million. GAAP net earnings increased to $113.9 million, up from $99 million last year. DCI raised its fiscal 2026 adjusted EPS guidance to $3.95-$4.11. Analysts updated price targets; Baird raised to $100, Stifel to $96. Shares dipped 1.8% on Friday, closing at $92.16.
View signal analysisDonaldson will report Q1 earnings on Dec. 3, estimates at 82 cents/share. Projected revenue of $893.49M, up from $846.3M last year. CFO Scott Robinson retires; Brad Pogalz takes over. Stifel downgraded price target from $76 to $71. Baird maintained Outperform rating but lowered target from $80 to $79.
View signal analysisDCI acquired a 49% stake in Medica for €62 million. Medica's filtration tech will expand DCI's market in medical devices. Past acquisitions include Univercells and Isolere to enhance life sciences segment. DCI shows growth potential despite rising operational costs. Stock performance lagged behind industry average, gaining only 13.5%.
View signal analysis